Inventor
VENTURINI ALESSIO
IT12 patents
⚠️ This page may combine multiple inventors who share the name “VENTURINI ALESSIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HELSINN HEALTHCARE SA
10 patentsUS11529362B2Dec 20, 2022
Physiologically balanced injectable formulations of fosnetupitant
HELSINN HEALTHCARE SA1 citations72
US10624911B2Apr 21, 2020
Physiologically balanced injectable formulations of fosnetupitant
HELSINN HEALTHCARE SA2 citations72
US10208073B2Feb 19, 2019
Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulator
HELSINN HEALTHCARE SA2 citations72
US9403772B2Aug 2, 2016
4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator
HELSINN HEALTHCARE SA4 citations72
US12208109B2Jan 28, 2025
Physiologically balanced injectable formulations of fosnetupitant
HELSINN HEALTHCARE SA0 citations62
US12071421B2Aug 27, 2024
Process for the synthesis of substituted chloromethyl dialkylphosphates
HELSINN HEALTHCARE SA0 citations61
US11312698B2Apr 26, 2022
Fosnetupitant chloride hydrochloride having improved stability
HELSINN HEALTHCARE SA0 citations61
US10717721B2Jul 21, 2020
Substituted piperaziniums for the treatment of emesis
HELSINN HEALTHCARE SA0 citations51
US9908907B2Mar 6, 2018
Substituted piperaziniums for the treatment of emesis
HELSINN HEALTHCARE SA0 citations51
US10005803B2Jun 26, 2018
Crystalline forms of fosnetupitant
HELSINN HEALTHCARE SA0 citations50